NTLA — Intellia Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology
Company fundamentals
| Metric | Cached value |
|---|---|
| Price (USD) | 11.89 |
| Market cap (USD) | 1,666,120,300 |
| P/E | -3.45 |
| ROE (%) | -57.79 |
| Net profit margin (%) | -783.64 |
| Revenue growth (%) | 16.92 |
| Dividend yield (%) | 0 |
Price last refreshed: .
Prices refreshed every 5 minutes during US market hours. Individual quotes may be older when provider data is missing or a refresh is incomplete. Check each quote's timestamp.
About Intellia Therapeutics, Inc.
Available company fundamentals for NTLA in Biotechnology. Values reflect cached source data, not live executable quotes. Valory Formula, when available, is informational analysis, not investment advice.